DNAフラグメント市場：タイプ別、製品タイプ別、用途別、エンドユーザー別 - 2025年～2030年の世界予測

DNAフラグメント市場は、2024年には20億6,000万米ドルとなり、2025年には22億3,000万米ドル、CAGR 8.18%で成長し、2030年には33億1,000万米ドルに達すると予測されています。

DNAフラグメント市場は、バイオテクノロジー、医学研究、治療開発の進展に不可欠な要素として浮上してきました。近年、急速な技術の進歩と遺伝子研究への注目の高まりが、DNAフラグメントの関連性を飛躍的に高めています。この急成長の背景には、診断、個別化医療、最先端研究における高精度のアプリケーションに対する需要の高まりがあります。世界中の研究所や研究機関が、配列精度の向上と新しい合成法を活用して、複雑な遺伝情報を探求しています。

合成生物学と遺伝子工学の進化は、科学的理解を深めるだけでなく、基礎科学と応用研究のギャップを埋めるイノベーションを育んできました。組織が研究能力の強化に努める中、天然および人工DNAフラグメントの統合が不可欠であることが証明されつつあります。本レポートでは、市場の現状を概説し、革新的な技術シフトを掘り下げ、的を絞った市場分析を可能にする詳細なセグメンテーションを提示しています。

さらに、世界市場は、競争戦略を形成し、投資決定に影響を与える多様な地域力学を示し続けています。このサマリーは、包括的な分析を通じて、課題に取り組み、将来の展望を明らかにしながら、進化する状況について明確な視点を提供することを目的としています。そうすることで、科学的洞察と市場情報の統合が、この複雑な業界をナビゲートしようとする利害関係者に強固な基盤を提供します。

DNAフラグメント市場の変革

DNAフラグメント市場は、画期的な技術革新と進化し続ける技術力によって変貌しつつあります。研究開発イニシアチブは、遺伝子合成とオリゴヌクレオチド生産における手法の進化を大きく推進し、効率と精度を向上させた高度に特殊なフラグメントの作成を可能にしました。

自動化とバイオインフォマティクスの急速な進歩は、ゲノム研究が機能する運営上の枠組みも再定義しました。改良された装置と合理化されたワークフローが相まって、DNA配列の生成と解析がかつてないスピードで可能になりつつあります。その結果、研究者は、技術的な限界よりも、むしろトランスレーショナルな成果に焦点を当てることができるようになりました。この変革は、遺伝子研究の伝統的なパラダイムに革命をもたらした、デジタルツール、データ解析、ロボット工学の研究室における戦略的統合によるところが大きいです。

さらに、規制の進化と学際的コラボレーションの増加は、カスタムDNAと合成DNAの両方の生産における革新への道を開いています。この情勢の変化は、多くのアプリケーションに影響を与え、新規参入者に最先端技術への投資を促しています。業界は現在、主に探索的な段階から、スケーラブルなソリューションと商業的導入に焦点を当てた段階へと移行しつつあり、持続可能な成長軌道を持つ、より成熟した市場の舞台を整えつつあります。

DNAフラグメント市場の詳細なセグメンテーション分析

綿密なセグメンテーション分析により、DNAフラグメント市場における戦略的意思決定を促進する幾層もの洞察が明らかになります。まず、タイプ別に市場を調査する場合、分析では二本鎖と一本鎖の断片を区別します。この分類は、設計の選択や最終用途に影響を与えるため非常に重要であり、特定の配列安定性要件に応じて技術革新を促進します。

製品タイプに目を移すと、市場はカスタムDNAと合成DNAのセグメントに分けられます。カスタムDNAは、独自の研究要件や実験デザインに対応し、特殊な遺伝子断片とともにオーダーメイドの遺伝子合成に焦点を当てています。対照的に、合成DNAはさらにロングオリゴとショートオリゴに細分化され、それぞれが診断、治療、様々な研究開発用途において明確な目的を果たします。この微妙な市場内訳により、市場ニーズと各カテゴリーを支える技術的進歩をより明確に理解することができます。

用途に基づくさらなる細分化は、バイオテクノロジー、医療、研究開発の各分野に及んでいます。バイオテクノロジー分野は、実験デザインとデータ解釈を強化するバイオインフォマティクスによる技術サポートによってさらに強化され、一方、医療分野は、予防的ヘルスケアニーズと反応的ヘルスケアニーズの両方に対応するため、診断薬と治療薬に綿密に区分されています。最後に、エンドユーザーセグメンテーションでは、学術・研究機関、病院・診療所、製薬会社など、主要な消費者グループを特定します。このような構造化されたアプローチは、明確な情報を提供するだけでなく、利害関係者が製品別や用途別の動向に基づいて戦略を立てられるようにするものです。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的に遺伝性疾患の罹患率が上昇
    • 世界中の消費者の間でパーソナライズ医療の需要が高まっている
    • ヘルスケア分野における遺伝子検査の認知度の高まり
  • 抑制要因
    • DNAフラグメント技術に関連する高コスト
  • 機会
    • 農業にDNAフラグメントを統合して収穫効率と病害抵抗性を高める
    • 迅速診断検査の開発におけるDNAフラグメントの活用
  • 課題
    • DNAフラグメントの取り扱いと処理に関するデータプライバシーの懸念
• 市場セグメンテーション分析
  • タイプ：従来の調査環境と臨床診断における二本鎖DNAフラグメントの好みの増加
  • 用途：バイオテクノロジーにおけるDNAフラグメントの応用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 DNAフラグメント市場：タイプ別

• 二重鎖
• 一本鎖

第7章 DNAフラグメント市場：製品タイプ別

• カスタムDNA
  • カスタム遺伝子合成
  • 遺伝子断片
• 合成DNA
  • ロングオリゴ
  • ショートオリゴ

第8章 DNAフラグメント市場：用途別

• バイオテクノロジー
  • バイオインフォマティクス
  • バイオテクノロジー
• 医療
  • 診断
  • 治療
• 研究開発

第9章 DNAフラグメント市場：エンドユーザー別

• 学術調査機関
• 病院・クリニック
• 製薬会社

第10章 南北アメリカのDNAフラグメント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のDNAフラグメント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのDNAフラグメント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies, Inc.
• Ansa Biotechnologies, Inc.
• Azenta Life Sciences
• BioVision Inc.
• DNA TwoPointO Inc.
• Eurofins Scientific SE
• Gene Universal, Inc.
• GenScript Biotech Corporation
• Illumina, Inc.
• Integrated DNA Technologies, Inc. by Danaher Corporation
• Merck KGaA
• Meridian Bioscience, Inc.
• Novartis AG
• Pacific Biosciences of California, Inc.
• QIAGEN N.V
• Synbio Technologies LLC
• Takara Bio USA, Inc.
• Thermo Fisher Scientific Inc.
• Twist Bioscience Corporation

LIST OF FIGURES

• FIGURE 1. DNA FRAGMENTS MARKET MULTI-CURRENCY
• FIGURE 2. DNA FRAGMENTS MARKET MULTI-LANGUAGE
• FIGURE 3. DNA FRAGMENTS MARKET RESEARCH PROCESS
• FIGURE 4. DNA FRAGMENTS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL DNA FRAGMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL DNA FRAGMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. DNA FRAGMENTS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. DNA FRAGMENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. DNA FRAGMENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL DNA FRAGMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DNA FRAGMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DNA FRAGMENTS MARKET DYNAMICS
• TABLE 7. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DOUBLE-STRANDED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SINGLE-STRANDED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CUSTOM GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DNA FRAGMENTS MARKET SIZE, BY GENE FRAGMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DNA FRAGMENTS MARKET SIZE, BY LONG OLIGOS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SHORT OLIGOS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DNA FRAGMENTS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DNA FRAGMENTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL DNA FRAGMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL DNA FRAGMENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CANADA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CANADA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CANADA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 61. CANADA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 62. CANADA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. CANADA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. CANADA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 65. CANADA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. CHINA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. CHINA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. CHINA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 103. CHINA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 104. CHINA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. CHINA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. CHINA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 107. CHINA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. INDIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. INDIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. INDIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 111. INDIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 112. INDIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. INDIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. INDIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 115. INDIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 120. INDONESIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. INDONESIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. INDONESIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 123. INDONESIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. JAPAN DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 127. JAPAN DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 128. JAPAN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. JAPAN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. JAPAN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 131. JAPAN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 135. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 136. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 139. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 143. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 144. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 147. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 151. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 152. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 155. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. TAIWAN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. TAIWAN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. TAIWAN DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 167. TAIWAN DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 168. TAIWAN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. TAIWAN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. TAIWAN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 171. TAIWAN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. THAILAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. THAILAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. THAILAND DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 175. THAILAND DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 176. THAILAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. THAILAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. THAILAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 179. THAILAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. VIETNAM DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. VIETNAM DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. VIETNAM DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 183. VIETNAM DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 184. VIETNAM DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. VIETNAM DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. VIETNAM DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 187. VIETNAM DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 191. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 192. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 197. DENMARK DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. DENMARK DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 199. DENMARK DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 200. DENMARK DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 201. DENMARK DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. DENMARK DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. DENMARK DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 204. DENMARK DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. EGYPT DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 206. EGYPT DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. EGYPT DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 208. EGYPT DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 209. EGYPT DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. EGYPT DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. EGYPT DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 212. EGYPT DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. FINLAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. FINLAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 215. FINLAND DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 216. FINLAND DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 217. FINLAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. FINLAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 219. FINLAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 220. FINLAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. FRANCE DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 222. FRANCE DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 223. FRANCE DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 224. FRANCE DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 225. FRANCE DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. FRANCE DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. FRANCE DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 228. FRANCE DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. GERMANY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 230. GERMANY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. GERMANY DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 232. GERMANY DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 233. GERMANY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. GERMANY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. GERMANY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 236. GERMANY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. ISRAEL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 238. ISRAEL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 239. ISRAEL DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 240. ISRAEL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 241. ISRAEL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 242. ISRAEL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 243. ISRAEL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 244. ISRAEL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 245. ITALY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 246. ITALY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 247. ITALY DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 248. ITALY DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 249. ITALY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. ITALY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 251. ITALY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 252. ITALY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 254. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 255. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 256. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 257. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 259. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 260. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 261. NIGERIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 262. NIGERIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 263. NIGERIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 264. NIGERIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 265. NIGERIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 266. NIGERIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 267. NIGERIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 268. NIGERIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 269. NORWAY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 270. NORWAY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 271. NORWAY DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 272. NORWAY DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 273. NORWAY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. NORWAY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 275. NORWAY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 276. NORWAY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 277. POLAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 278. POLAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 279. POLAND DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 280. POLAND DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 281. POLAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. POLAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 283. POLAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 284. POLAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 285. QATAR DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 286. QATAR DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 287. QATAR DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 288. QATAR DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 289. QATAR DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 290. QATAR DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 291. QATAR DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 292. QATAR DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 293. RUSSIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 294. RUSSIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 295. RUSSIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 296. RUSSIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 297. RUSSIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 298. RUSSIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 299. RUSSIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 300. RUSSIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 301. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 302. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 303. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 304. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 305. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 306. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 307. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 308. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 309. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 310. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 311. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 312. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 313. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 314. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 315. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 316. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 317. SPAIN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 318. SPAIN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 319. SPAIN DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 320. SPAIN DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 321. SPAIN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 322. SPAIN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 323. SPAIN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 324. SPAIN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 325. SWEDEN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 326. SWEDEN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 327. SWEDEN DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 328. SWEDEN DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 329. SWEDEN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 330. SWEDEN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 331. SWEDEN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 332. SWEDEN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 333. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 334. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 335. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 336. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 337. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 338. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 339. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 340. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 341. TURKEY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 342. TURKEY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 343. TURKEY DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 344. TURKEY DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 345. TURKEY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 346. TURKEY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 347. TURKEY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 348. TURKEY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 349. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 350. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 351. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 352. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 353. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 354. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 355. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 356. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 357. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 358. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 359. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
• TABLE 360. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
• TABLE 361. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 362. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 363. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 364. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 365. DNA FRAGMENTS MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 366. DNA FRAGMENTS MARKET, FPNV POSITIONING MATRIX, 2024

The DNA Fragments Market was valued at USD 2.06 billion in 2024 and is projected to grow to USD 2.23 billion in 2025, with a CAGR of 8.18%, reaching USD 3.31 billion by 2030.

The DNA fragments market has emerged as a critical component in the advancement of biotechnology, medical research, and therapeutic developments. In recent years, rapid technological advancements and a heightened focus on genetic research have catapulted the relevance of DNA fragments. This surge is driven by an increasing demand for high-precision applications in diagnostics, personalized medicine, and cutting-edge research. Laboratories and institutions around the world are leveraging improved sequence accuracy and novel synthesis methods to explore intricate genetic information.

The evolution of synthetic biology and genetic engineering has not only enriched the scientific understanding but also fostered innovations that bridge the gap between basic science and applied research. As organizations strive to enhance research capabilities, the integration of both natural and engineered DNA fragments is proving indispensable. This report outlines the current market conditions, dives into transformative technological shifts, and presents an in-depth segmentation that enables targeted market analyses.

Moreover, the global market continues to witness a diverse range of regional dynamics that shape competitive strategies and influence investment decisions. Through a comprehensive analysis, this summary aims to offer a clear perspective on the evolving landscape while addressing challenges and highlighting future prospects. In doing so, the synthesis of scientific insights with market intelligence provides a robust foundation for stakeholders seeking to navigate this complex industry.

Transformative Shifts in the DNA Fragments Landscape

The landscape of the DNA fragments market is witnessing transformative shifts fueled by groundbreaking innovations and ever-evolving technological capabilities. Research and development initiatives have significantly propelled the evolution of methods in gene synthesis and oligonucleotide production, enabling the creation of highly specialized fragments with improved efficiency and accuracy.

Rapid advancements in automation and bioinformatics have also redefined the operational framework within which genomic research functions. Enhanced instrumentation, coupled with streamlined workflows, is making it possible to generate and analyze DNA sequences at unprecedented speeds. As a result, researchers can now focus more on translational outcomes rather than technical limitations. This transformation is largely due to the strategic integration of digital tools, data analytics, and robotics in laboratory settings which have revolutionized the traditional paradigms of genetic research.

Additionally, regulatory evolutions and increasing cross-disciplinary collaborations are paving the way for innovations in both custom and synthetic DNA production. This change in landscape is influencing numerous applications and encouraging new entrants to invest in state-of-the-art technologies. The industry is now moving from a predominantly exploratory phase to one that is focused on scalable solutions and commercial implementation, setting the stage for a more mature market with sustainable growth trajectories.

In-Depth Segmentation Analysis of DNA Fragments Market

An in-depth segmentation analysis reveals several layers of insights that drive strategic decision-making in the DNA fragments market. First, when studying the market based on type, the analysis distinguishes between double-stranded and single-stranded fragments. This categorization is critical as it influences design choices and end-use applications, driving innovation depending on specific sequence stability requirements.

Moving on to the product type, the market is dissected into custom DNA and synthetic DNA segments. Custom DNA focuses on tailored gene synthesis along with specialized gene fragments, addressing unique research requirements and experimental designs. In contrast, synthetic DNA is further subdivided into long oligos and short oligos, each serving distinct purposes in diagnostics, therapeutics, and various R&D applications. This nuanced breakdown facilitates a clearer understanding of market needs and the technological advancements that underpin each category.

Further segmentation based on application spans biotechnology, medical, and research and development sectors. The biotechnology segment is further enhanced by technological support from bioinformatics, which fortifies experimental design and data interpretation, while the medical segment is meticulously divided into diagnostics and therapeutics to address both preventative and reactive healthcare needs. Finally, the end-user segmentation identifies key consumer groups, including academic and research institutes, hospitals and clinics, and pharmaceutical companies. This structured approach not only provides clarity but also empowers stakeholders to tailor their strategies based on product-specific and application-centered trends.

Based on Type, market is studied across Double-Stranded and Single-Stranded.

Based on Product Type, market is studied across Custom DNA and Synthetic DNA. The Custom DNA is further studied across Custom Gene Synthesis and Gene Fragments. The Synthetic DNA is further studied across Long Oligos and Short Oligos.

Based on Application, market is studied across Biotechnology, Medical, and Research & Development. The Biotechnology is further studied across Bioinformatics and Biotechnology. The Medical is further studied across Diagnostics and Therapeutics.

Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Clinics, and Pharmaceutical Companies.

Global Regional Dynamics in the DNA Fragments Market

The global dynamics of the DNA fragments market are characterized by considerable regional diversity that contributes significantly to the evolution of market trends. In the Americas, there is a pronounced emphasis on advanced research infrastructure and substantial investment in biotechnology, driving the adoption of both custom and synthetic DNA solutions. Economic stability and robust funding structures in this region further enhance the capabilities of research facilities to implement state-of-the-art technologies.

The Europe, Middle East & Africa region presents a unique blend of established research institutions and emerging innovation hubs. Regulatory reforms, coupled with intensive research collaborations, have fostered an environment conducive to accelerating product development and expanding market reach. In this region, there is a consistent focus on bridging traditional research methodologies with modern biotechnological advancements, resulting in a competitive yet collaborative ecosystem.

In the Asia-Pacific region, rapid industrialization combined with significant government support has led to a surge in laboratory innovations and research initiatives. This dynamic market environment is bolstered by a growing number of start-ups, dedicated research clusters, and multinational collaborations. The convergence of resource availability and technological expertise in the Asia-Pacific makes it a pivotal region where trends in custom and synthetic DNA are evolving most rapidly. Each of these regions contributes uniquely to the market, presenting a rich tapestry of opportunities and challenges that demand tailored strategic responses from market participants.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Market Players

The competitive landscape in the DNA fragments market is defined by the participation of key industry players who drive innovation and market value. Prominent companies such as Abbott Laboratories, Agilent Technologies, Inc., and Ansa Biotechnologies, Inc. have set high benchmarks in quality and precision through their advanced research and development initiatives. Leading firms also include Azenta Life Sciences, BioVision Inc., and DNA TwoPointO Inc. which are recognized for their innovative approaches and rapid adaptation to market needs.

In addition, Eurofins Scientific SE and Gene Universal, Inc. have expanded their market presence by continuously evolving their product portfolios to meet shifting research demands. GenScript Biotech Corporation and Illumina, Inc. have demonstrated exceptional capability in synthesizing complex DNA fragments, thereby catering to a wide array of applications. Further enhancing the competitive matrix, Integrated DNA Technologies, Inc. by Danaher Corporation, Merck KGaA, and Meridian Bioscience, Inc. remain at the forefront with their robust distribution networks and cutting-edge technology integrations.

Other significant players such as Novartis AG, Pacific Biosciences of California, Inc., and QIAGEN N.V have carved out substantial market niches by capitalizing on their extensive research backgrounds. Synbio Technologies LLC, Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Twist Bioscience Corporation further consolidate the landscape by offering specialized solutions that meet bespoke research needs. Together, these companies form a diverse ecosystem, continually influencing market trends and driving the momentum towards a more innovative future in DNA fragment research and applications.

The report delves into recent significant developments in the DNA Fragments Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Ansa Biotechnologies, Inc., Azenta Life Sciences, BioVision Inc., DNA TwoPointO Inc., Eurofins Scientific SE, Gene Universal, Inc., GenScript Biotech Corporation, Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Merck KGaA, Meridian Bioscience, Inc., Novartis AG, Pacific Biosciences of California, Inc., QIAGEN N.V, Synbio Technologies LLC, Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Twist Bioscience Corporation. Actionable Strategic Recommendations for Market Stakeholders

For industry leaders and market stakeholders aiming to secure competitive advantages in the DNA fragments space, several actionable strategic recommendations emerge from the current market analysis. First, it is essential to invest in next-generation sequencing and synthesis technologies. With rapid improvements being introduced in automated and real-time analytical tools, stakeholders should prioritize research and development initiatives that ensure precision and scalability in fragment synthesis.

Leaders are encouraged to build robust partnerships across interdisciplinary fields-bridging genomic research with data analytics and bioinformatics. Such collaborations can facilitate accelerated research outcomes and foster innovation in both product development and application-specific customization. Furthermore, aligning strategic investments with emerging market trends in both custom and synthetic DNA segments can help capture evolving consumer demands and optimize operational efficiencies.

Diversification of product portfolios should not be overlooked. Stakeholders are recommended to expand their offerings, accommodating targeted needs across various segments such as tailored gene synthesis, long and short oligonucleotides, and specialized diagnostic tools. Embracing a global perspective by tailoring solutions to regional dynamics will ensure enhanced market penetration in diverse economic settings. Lastly, maintaining a forward-thinking approach by monitoring regulatory environments and investing in sustainable practices will secure long-term competitive advantages in an increasingly complex market landscape.

Conclusion and Future Outlook in DNA Fragments

In conclusion, the DNA fragments market stands at the nexus of scientific innovation, technological progress, and strategic market development. The convergence of high-precision gene synthesis, advanced automation, and robust research collaborations has led to an environment where emerging technologies and market demands are aligned to foster transformative growth. Comprehensive segmentation and regional analyses underscore the diverse avenues through which product innovations are reshaping the industry. The inclusion of customized and synthetic approaches provides companies with the flexibility to address both niche and broad-spectrum market needs.

Looking ahead, the interplay between innovative research and application-driven development is expected to persist as a defining factor for future growth. As market players strategically position themselves within evolving regional ecosystems and invest in cutting-edge technologies, the DNA fragments industry is poised for significant expansion. This summary provides a foundational understanding and a roadmap for stakeholders, emphasizing the critical need for a balanced approach that integrates operational excellence with strategic foresight.

Ultimately, the pathway forward will depend on the ability to harness current trends, address emerging challenges, and continuously innovate. With relentless advancements in genomic research on the horizon, industry leaders can expect dynamic shifts that will further consolidate the promise of the DNA fragments market in the years to come.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of genetic disorders globally
    • 5.1.1.2. Growing demand for personalized medicine among consumers globally
    • 5.1.1.3. Rising awareness of genetic testing in the healthcare sector
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with DNA fragment technology
  • 5.1.3. Opportunities
    • 5.1.3.1. Integrating DNA fragments in agriculture to boost yield efficiency and disease resistance
    • 5.1.3.2. Utilizing DNA fragments in the development of rapid diagnostic tests
  • 5.1.4. Challenges
    • 5.1.4.1. Data privacy concerns over the handling and processing of DNA fragments
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing preference for double-stranded DNA fragments in traditional research settings and clinical diagnostics
  • 5.2.2. Application: Expanding application of DNA fragments in biotechnology
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. DNA Fragments Market, by Type

• 6.1. Introduction
• 6.2. Double-Stranded
• 6.3. Single-Stranded

7. DNA Fragments Market, by Product Type

• 7.1. Introduction
• 7.2. Custom DNA
  • 7.2.1. Custom Gene Synthesis
  • 7.2.2. Gene Fragments
• 7.3. Synthetic DNA
  • 7.3.1. Long Oligos
  • 7.3.2. Short Oligos

8. DNA Fragments Market, by Application

• 8.1. Introduction
• 8.2. Biotechnology
  • 8.2.1. Bioinformatics
  • 8.2.2. Biotechnology
• 8.3. Medical
  • 8.3.1. Diagnostics
  • 8.3.2. Therapeutics
• 8.4. Research & Development

9. DNA Fragments Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Hospitals & Clinics
• 9.4. Pharmaceutical Companies

10. Americas DNA Fragments Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific DNA Fragments Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa DNA Fragments Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. IDT expands synthetic biology capacity with new Coralville Facility to meet growing global demand
  • 13.3.2. Twist Bioscience enhances DNA fragment synthesis with Multiplexed Gene Fragments for enhanced high-throughput screening
  • 13.3.3. Codexis teams up with Roche to enhance next-generation sequencing with innovative DNA ligase tech
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Ansa Biotechnologies, Inc.
• 4. Azenta Life Sciences
• 5. BioVision Inc.
• 6. DNA TwoPointO Inc.
• 7. Eurofins Scientific SE
• 8. Gene Universal, Inc.
• 9. GenScript Biotech Corporation
• 10. Illumina, Inc.
• 11. Integrated DNA Technologies, Inc. by Danaher Corporation
• 12. Merck KGaA
• 13. Meridian Bioscience, Inc.
• 14. Novartis AG
• 15. Pacific Biosciences of California, Inc.
• 16. QIAGEN N.V
• 17. Synbio Technologies LLC
• 18. Takara Bio USA, Inc.
• 19. Thermo Fisher Scientific Inc.
• 20. Twist Bioscience Corporation